查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2060247

即時PCR、數位螢光定量PCR和終點螢光定量PCR市場分析及預測（至2035年）：類型、產品類型、服務、技術、組件、應用、最終用戶、功能、解決方案、方法

Real-Time PCR, Digital PCR, and End-point PCR Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Functionality, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球即時PCR、數位螢光定量PCR和終點螢光定量PCR市場預計將從2025年的111億美元成長到2035年的255億美元，年複合成長率（CAGR）為8.7%。即時PCR螢光定量PCR技術是推動PCR市場成長的主要動力，該技術廣泛應用於診斷和研究領域。基因檢測和感染疾病檢測需求的不斷成長進一步促進了這一成長。各公司正致力於提高技術的靈敏度、準確性和速度。策略聯盟和收購正在推動技術進步。全球醫療、生物技術和研究領域的廣泛應用也為市場帶來了正面影響。

即時PCR、數位PCR和終點PCR市場的技術發展主要得益於檢測靈敏度、特異性和速度的不斷提升。在眾多關鍵技術中，TaqMan和SYBR Green檢測因其可靠性和在基因表現分析及病原體檢測中的廣泛應用而佔據市場主導地位。 TaqMan透過探針檢測提供高特異性，而SYBR Green則因其成本效益和操作簡便而備受青睞。多重PCR和高通量系統的日益普及進一步加速了市場成長，尤其是在基因組學和個人化醫療領域，快速且準確地分析多個標靶至關重要。

市場區隔
類型 即時PCR、數位PCR、終點PCR及其他
產品 設備、試劑及耗材、軟體及其他
服務 校準服務、維護服務、訓練服務等。
科技 TaqMan探針法、SYBR Green法、溶離曲線分析等。
成分 聚合酵素連鎖反應熱迴圈儀、PCR管、PCR板及其他物品。
目的 臨床診斷、研究、法醫學、農業用途等。
最終用戶 醫院和診斷中心、研究實驗室、製藥和生物技術公司、學術機構及其他
功能 定量PCR、定性PCR及其他
解決方案 客製化檢測、標準檢測及其他
模式 自動、手動、其他

終端用戶市場主要由醫院和診斷實驗室驅動，這些機構高度依賴PCR技術進行快速且準確的疾病診斷。這些機構利用PCR技術檢測感染疾病、遺傳性疾病和癌症生物標記物，因此是市場需求的最大驅動力。學術和研究機構也是重要的市場組成部分，這主要得益於基因組學、分子生物學和藥物研發領域的持續研究。此外，製藥和生技公司正在擴大PCR技術在臨床試驗、藥物研發和品管流程中的應用，凸顯了該技術在推動醫療創新方面日益成長的重要性。

區域概覽

北美PCR市場高度成熟，主要得益於診斷和科研應用領域的高普及率。美國憑藉其先進的實驗室基礎設施和對分子檢測的強勁需求，引領市場發展。感染疾病檢測和基因分析領域PCR應用的日益廣泛也推動了市場成長。加拿大透過不斷提昇科研能力，為市場做出了貢獻。持續的技術進步不斷提高PCR系統的準確性和效率。主要市場參與者的強大實力也進一步推動了市場的發展。

由於對分子診斷和研究活動的需求不斷成長，亞太地區的PCR市場正在快速擴張。中國、印度和日本等國家是主要貢獻者。醫療保健投資的增加和生物技術行業的成長正在推動PCR技術的應用。感染疾病的蔓延也支撐了市場需求。診斷實驗室的擴建提高了PCR技術的可近性。

主要趨勢和促進因素

PCR技術的進步：

即時PCR、數位螢光定量PCR和終點螢光定量PCR市場正經歷快速的技術進步，檢測過程的準確性、靈敏度和效率不斷提升。多重螢光定量PCR和高通量系統等創新技術能夠同時檢測多個標靶，進而增強診斷能力。這些進步在感染疾病檢測、腫瘤學和基因分析領域尤其重要。自動化程度的提高和處理時間的縮短也促進了檢查室效率的提升。隨著技術的不斷發展，螢光定量PCR系統變得更加普及和經濟實惠，進一步推動了其在科學研究和臨床應用中的普及。

對分子診斷日益成長的需求：

分子診斷需求的不斷成長是PCR市場的主要驅動力。 PCR技術被廣泛用於快速、準確地檢測疾病，包括感染疾病和遺傳性疾病。隨著早期診斷和個人化醫療的日益普及，人們對基於PCR的檢測方法的依賴性也隨之增強。此外，全球健康挑戰凸顯了高效診斷工具的重要性。醫療系統正在投資建造先進的診斷基礎設施，以改善患者的治療效果。這種對準確、快速診斷日益成長的需求是全球PCR市場成長的主要驅動力。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 即時PCR
    • 數位PCR
    • 終點PCR
    • 其他
  • 市場規模及預測：依產品分類
    • 裝置
    • 試劑和耗材
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 校對服務
    • 維護服務
    • 培訓服務
    • 其他
  • 市場規模及預測：依技術分類
    • TaqMan探針基礎
    • SYBR Green 底色
    • 熔解曲線分析
    • 其他
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 出於研究目的
    • 在法醫學領域的應用
    • 農業領域的用途
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院和診斷中心
    • 研究所
    • 製藥和生物技術公司
    • 學術機構
    • 其他
  • 市場規模及預測：依組件分類
    • 聚合酵素連鎖反應熱迴圈儀
    • PCR管
    • PCR板
    • 其他
  • 市場規模及預測：依功能分類
    • 定量PCR
    • 定性PCR
    • 其他
  • 市場規模及預測：按解決方案分類
    • 客製化檢測
    • 標準檢測
    • 其他
  • 市場規模及預測：依方法
    • 自動化
    • 手動的
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • QIAGEN
  • Roche Diagnostics
  • Agilent Technologies
  • Takara Bio
  • Merck KGaA
  • Promega Corporation
  • Fluidigm Corporation
  • Analytik Jena
  • Eppendorf AG
  • Illumina
  • LGC Biosearch Technologies
  • Bioline
  • Stilla Technologies
  • Biomeme
  • Cepheid
  • Bioneer Corporation
  • Norgen Biotek
  • GeneCopoeia

第9章 關於我們

簡介目錄
Product Code: GIS26975

The global Real-Time PCR, Digital PCR, and End-point PCR market is projected to grow from $11.1 billion in 2025 to $25.5 billion by 2035, at a compound annual growth rate (CAGR) of 8.7%. The PCR Market is led by real-time PCR technology, widely used in diagnostics and research. Growth is driven by increasing demand for genetic testing and infectious disease detection. Companies focus on improving sensitivity, accuracy, and speed. Strategic partnerships and acquisitions support technological advancement. The market benefits from strong adoption in healthcare, biotech, and research sectors globally.

The Technology segment in the Real-Time PCR, Digital PCR, and End-point PCR market is driven by continuous advancements that improve sensitivity, specificity, and speed of detection. Among the key technologies, TaqMan and SYBR Green assays dominate due to their reliability and widespread use in gene expression analysis and pathogen detection. TaqMan offers higher specificity through probe-based detection, while SYBR Green is preferred for its cost-effectiveness and simplicity. Increasing adoption of multiplex PCR and high-throughput systems is further accelerating market growth, particularly in genomics and personalized medicine, where rapid and accurate analysis of multiple targets is essential.

Market Segmentation
TypeReal-Time PCR, Digital PCR, End-point PCR, Others
ProductInstruments, Reagents and Consumables, Software, Others
ServicesCalibration Services, Maintenance Services, Training Services, Others
TechnologyTaqMan Probe-Based, SYBR Green-Based, Melt Curve Analysis, Others
ComponentThermal Cyclers, PCR Tubes, PCR Plates, Others
ApplicationClinical Diagnostics, Research Applications, Forensic Applications, Agricultural Applications, Others
End UserHospitals and Diagnostic Centers, Research Laboratories, Pharmaceutical and Biotechnology Companies, Academic Institutions, Others
FunctionalityQuantitative PCR, Qualitative PCR, Others
SolutionsCustom Assays, Standard Assays, Others
ModeAutomated, Manual, Others

The End User segment is primarily led by hospitals and diagnostic laboratories, which rely heavily on PCR technologies for rapid and precise disease diagnosis. These facilities use PCR for detecting infectious diseases, genetic disorders, and cancer biomarkers, making them the largest contributors to market demand. Academic and research institutions also represent a significant segment, driven by ongoing studies in genomics, molecular biology, and drug discovery. Additionally, pharmaceutical and biotechnology companies are increasingly adopting PCR technologies for clinical trials, drug development, and quality control processes, highlighting the technologyas growing importance in advancing healthcare innovation.

Geographical Overview

The PCR market in North America is highly mature, driven by strong adoption in diagnostics and research applications. The United States leads due to advanced laboratory infrastructure and high demand for molecular testing. Increasing use in infectious disease detection and genetic analysis supports growth. Canada contributes through expanding research capabilities. Continuous technological advancements improve accuracy and efficiency of PCR systems. Strong presence of key market players further enhances development.

The Asia-Pacific PCR market is rapidly expanding due to increasing demand for molecular diagnostics and research activities. Countries such as China, India, and Japan are key contributors. Rising healthcare investments and growing biotech sectors drive adoption. Increasing prevalence of infectious diseases supports demand. Expansion of diagnostic labs enhances accessibility.

Key Trends and Drivers

Advancements in PCR Technology:

The real-time PCR, digital PCR, and end-point PCR market is witnessing rapid technological advancements, enhancing the accuracy, sensitivity, and efficiency of testing processes. Innovations such as multiplex PCR and high-throughput systems are enabling simultaneous detection of multiple targets, improving diagnostic capabilities. These advancements are particularly valuable in infectious disease detection, oncology, and genetic analysis. Improved automation and reduced processing times are also increasing laboratory efficiency. As technology continues to evolve, PCR systems are becoming more accessible and cost-effective, further supporting their widespread adoption across research and clinical applications.

Increasing Demand for Molecular Diagnostics:

The rising demand for molecular diagnostics is a major driver of the PCR market. PCR technologies are widely used for rapid and accurate detection of diseases, including infectious and genetic disorders. The growing emphasis on early diagnosis and personalized medicine is increasing reliance on PCR-based testing. Additionally, global health challenges have highlighted the importance of efficient diagnostic tools. Healthcare systems are investing in advanced diagnostic infrastructure to improve patient outcomes. This increasing need for precise and timely diagnostics is significantly driving the growth of the PCR market worldwide.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Real-Time PCR
    • 4.1.2 Digital PCR
    • 4.1.3 End-point PCR
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Instruments
    • 4.2.2 Reagents and Consumables
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Calibration Services
    • 4.3.2 Maintenance Services
    • 4.3.3 Training Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 TaqMan Probe-Based
    • 4.4.2 SYBR Green-Based
    • 4.4.3 Melt Curve Analysis
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Diagnostics
    • 4.5.2 Research Applications
    • 4.5.3 Forensic Applications
    • 4.5.4 Agricultural Applications
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals and Diagnostic Centers
    • 4.6.2 Research Laboratories
    • 4.6.3 Pharmaceutical and Biotechnology Companies
    • 4.6.4 Academic Institutions
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Thermal Cyclers
    • 4.7.2 PCR Tubes
    • 4.7.3 PCR Plates
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Quantitative PCR
    • 4.8.2 Qualitative PCR
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Custom Assays
    • 4.9.2 Standard Assays
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Manual
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Thermo Fisher Scientific
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio-Rad Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 QIAGEN
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Roche Diagnostics
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Agilent Technologies
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Takara Bio
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Merck KGaA
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Promega Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Fluidigm Corporation
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Analytik Jena
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Eppendorf AG
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Illumina
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 LGC Biosearch Technologies
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Bioline
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Stilla Technologies
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Biomeme
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Cepheid
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Bioneer Corporation
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Norgen Biotek
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 GeneCopoeia
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us